In its judgment of December 17, 2020 in case C-490/19, the Court of Justice of the European Union (“CJEU”) specified
Read MoreIndustrial property
Cooperation agreement between the EU and the UK: Intellectual and Industrial Property provisions
On December 24, the European Commission finally reached an agreement with the UK on the terms of their future cooperation
Read MoreCan a trademark holder prevent its agent from registering a similar trademark for itself? CJEU judgment in the Magic Minerals case
In November, the Court of Justice of the European Union (“CJEU”) issued a judgment ruling on the appeal in cassation
Read MoreWhen does an indirect patent infringement occur? Judgment of the Barcelona Provincial Court
Imagine that a company has obtained a process patent for regenerating bone tissue, the subject matter being the preparation of
Read MoreAction Plan on Intellectual and Industrial Property to strengthen the EU’s economic resilience and recovery
Taking the EU’s new industrial strategy, adopted on March 10, as a starting point, as well as intellectual and industrial
Read MoreFerrari takes pole position in the genuine use of its trademarks: “Testarossa” case
In its judgment of October 22, 2020 in the Ferrari v DU case, the Court of Justice of the European
Read MoreSupreme Court judgment: the scope of judicial review assessing industrial design infringements
In its judgment 537/2020 of October 16, 2020, the Spanish Supreme Court (“TS”) ruled on a case clarifying controversial aspects
Read MoreTrademark invalidity due to registration of Banksy’s urban art in bad faith
Until September, the so-called “Flower Thrower” — a work by the British artist operating under the pseudonym “Banksy” — not
Read MoreThe European Commission launches a public consultation on the protection and enforcement of intellectual property rights in third countries
On September 14, 2020, in the framework of the European Union’s Strategy for the protection and enforcement of intellectual property
Read MoreNew therapeutic applications of already authorized active ingredients and SPCS: the CJEU reviews its position on Neurim (CJEU judgment 07.09.2020, Santen Case, C-673/18)
Supplementary Protection Certificates (SPCs) for medicines and, in particular, the requirements they must meet to be granted have generated a significant
Read More